Cancer Research - GoKawiil

Whitehead Institute uses Google's AI Co-Scientist to target MYC-driven cancer

Biochemist Anna Pertl at the Whitehead Institute prompted an AI system called Co-Scientist to generate novel strategies for disrupting molecular condensates that fuel the cancer-driving protein MYC. Unlike a simple chatbot, the tool deploys multiple autonomous agents that search literature, debate competing explanations, and iteratively refine hypotheses before returning results, a process that can take hours. The work builds on prior findings by her supervisor Richard Young, whose lab showed cancer cells hijack condensates at super-enhancers to overproduce MYC, research now being pursued commercially through his company Dewpoint Therapeutics.

nature.com · 2026-09-21

Study finds tumour cells actively remodel surrounding tissue to evade immune attack

Researchers report that cancer cells don't just passively resist immune detection—they actively alter the tissue around them to create a protective microenvironment. This process helps shield tumours from being recognized and destroyed by the body's immune defenses.

nature.com · 2026-09-16

Arm CEO Rene Haas: chip shortage is slowing AI-driven cancer research

Rene Haas, chief executive of Arm Holdings, told the BBC that AI will eventually cure cancer by modelling complex cellular and DNA processes beyond current human or computing capability, though he said this progress is being constrained by a shortage of chips needed to build data centres. He also predicted humanoid robots would become widespread within five years, while expressing doubt that chip manufacturing could realistically be built up in the UK.

bbc.co.uk · 2026-09-07